
Dain, PhD
@dainjaaa
PhD in Exercise Physiology.
ID: 1152215594839805952
19-07-2019 13:56:19
302 Tweet
335 Followers
371 Following

Our #ArticleinPress for today raises a question from Uni Duisburg-Essen @unidue.bsky.social, Low-Level Tragus Stimulation as a treatment for primary hypertension - a systemic reaction with a broader cardioprotective potential? (Umut Paket): ow.ly/waBT50V0ump #VagusNerve #Hypertension




dyk that women were excluded from clinical trials until the ‘90s 🤯. This had huge consequences for women’s health. The NIH Sex as a Biological Variable policy was meant to ensure female inclusion in studies & now it appears it’s being quietly dismantled. thetransmitter.org/policy/exclusi…

1.9 billion people are projected to be living with obesity by 2035, including a doubling of childhood obesity from 2020 levels by 2035. On #WorldObesityDay, the latest Editorial from The Lancet Public Health looks at how we can tackle the obesity crisis by addressing obesogenic


A new look at brain dopamine responses to ultra-processed milkshakes. Highly variable and not significantly related to adiposity in humans #obesity Kevin Hall Cell Metabolism NIH cell.com/cell-metabolis…?



Inspired by Daniel J Drucker and others. Cc Team Novo Nordisk




If you are a scientist or engineer and want to help Congress shape AI policy over the next year - S&TPolicyFellowships is seeking applications with a May 1 deadline. Fellows will be extraordinary assets in helping Congress understand political, social, cyber and economic impacts of AI.

How does anti-tick immunity work? Scientists create a rapid antigen monitoring platform (IscREAM) and profile immune responses to #Iscapularis #tick cement proteins in humans, providing a resource for future anti-tick vaccines. Thomas Hart Molecular Microbiology and Immunology at JHSPH scim.ag/4l8u9uO


Ever wondered what it takes to bring a life-changing drug to market? My latest blog post, "A Billion-Dollar Gamble: How Drugs Are Developed," dives into the high-stakes world of pharmaceutical innovation. American Physiological Society #DrugDevelopment #Pharma ispyphysiology.com/2025/04/23/a-b…

The expanding universe of GLP-1 medicines-with dozens of new molecular entities in the clinic, how will they differentiate beyond #weightloss #obesity #diabetes #heartdiseasen Nature Reviews Drug Discovery nature.com/articles/s4157…


This week on the #ISpyPhysiology blog, APS member and #APS2025 blogger Macy Stahl writes about a Summit game-changer session that discussed the benefits of #GLP1 drugs for more than just weight loss: ow.ly/B3z150VSO4N


Red blood cells drive endothelial dysfunction in #diabetes! Read our article in Journal of Clinical Investigation where we discuss the recent findings from the #PernowLab: jci.org/articles/view/… CTEC - Zurich University Heart Center #SarahCostantino Shafeeq mohammed Era Gorica
